Last updated: May 29, 2026

Application No. 18/270,518

IVERMECTIN FORMULATION IN ORAL SOLUTION

Non-Final OA

Filed

Jun 30, 2023

Priority

Dec 30, 2020 — nonprovisional of PCTIB2020062551

Examiner

WISTNER, SARAH CLINKSCALES

Art Unit

1616

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Procaps S A

OA Round

1 (Non-Final)

This examiner grants 20% of cases after interview

— +68.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 20 resolved cases, 2023–2026

Examiner Intelligence

WISTNER, SARAH CLINKSCALES View full profile →

Grants only 20% of cases

Career Allowance Rate

4 granted / 20 resolved

-40.0% vs TC avg

Strong +69% interview lift

Without

With

+68.8%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

38 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

36.5%

-3.5% vs TC avg

§102

5.1%

-34.9% vs TC avg

§112

1.3%

-38.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 20 resolved cases

Prosecution Timeline

Jun 30, 2023

Application Filed

Jan 23, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/739,090

Patent 12343434

Hybrid membrane camouflaged nanomedicine loaded with oxidative phosphorylation inhibitor and preparing method thereof

3y 1m to grant Granted Jul 01, 2025

17/264,832

Patent 12329162

Methods for Enhancing Root Strength and Safety of Turf Grass

4y 4m to grant Granted Jun 17, 2025

17/233,101

Patent 12285539

HEMOSTATIC COMPOSITIONS AND RELATED METHODS

4y 0m to grant Granted Apr 29, 2025

Study what changed to get past this examiner. Based on 3 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

20%

Grant Probability

89%

With Interview (+68.8%)

3y 4m (~5m remaining)

Median Time to Grant

Low

PTA Risk

Based on 20 resolved cases by this examiner. Grant probability derived from career allowance rate.